‘Could we’ve waited for Phase 3 trials?… But should we not save 50,000 lives?… There is no risk to anyone’ - Newshunt

‘Could we’ve waited for Phase 3 trials?… But should we not save 50,000 lives?… There is no risk to anyone’

As chief of CSIR, which has a network of 37 of India’s premier research labs, Mande has been at the centre of govt’s Covid-19 response strategy. As vaccination begins, his team will be part of the pharmacov- igilance process for next 2 years


from Sports News, Latest Sports News Headlines, Cricket News Today, World Cup 2019, Football News, Tennis News, Live Scores | The Indian Express
Read The Rest:indianexpress....

No comments:

Powered by Blogger.